In a similar, more recent study using APP/PS1 model, 8 weeks administration of Agathobaculum butyriciproducens (SR79) significantly improved cognitive performance in the novel object recognition test and Y-maze at the overt stage of AD-like pathology, together with decreased Aβ plaque deposition and microglia activation. Here, APP is linked to Alzheimer disease.